acquired xanthinuria
Acquired xanthinuria is generally iatrogenic. Allopurinol treatment, administered to block XOR and prevent uric acid overproduction, leads to the accumulation of xanthine. Rarely, in the setting of aggressive chemotherapy with rapid tumor lysis or in patients with HPRT deficiency on allopurinol therapy, complications of renal failure can develop from xanthine crystal nephropathy.
MONDO:0000721
xanthinuria
is_a
MONDO:0006504
acquired metabolic disease
is_a
acquired xanthinuria
exact